Ge et al. studied the role of blockade of these proteins in human HCC tissue and found that co-blockade of TIGIT and PD-1 resulted in an enhanced proliferation of CD8+ T in nivolumab non-responders [144]. This evidence concerns the gene TIGIT and hepatocellular carcinoma.